003520.KS | Yungjin Pharm. Co., Ltd. Annual & Quarterly

Annual Balance Sheets

(In KRW)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	226.6 Billion	203.08 Billion	194.09 Billion	188.1 Billion	200.44 Billion	196.11 Billion
Total Current Assets	126.56 Billion	102.19 Billion	89.68 Billion	98.67 Billion	111.33 Billion	109.68 Billion
Cash And Short Term Investments	10.2 Billion	682.25 Million	464.57 Million	427.68 Million	651.87 Million	1.83 Billion
Cash and Cash Equivalents	7.2 Billion	682.25 Million	464.57 Million	427.68 Million	651.87 Million	1.83 Billion
Short Term Investments	3 Billion	-1.38 Billion	-2.23 Billion	-2.23 Billion	-1.37 Billion	-3.93 Billion
Net Receivables	54.16 Billion	53.04 Billion	49.35 Billion	46.26 Billion	54.72 Billion	60.01 Billion
Inventory	61.98 Billion	48.46 Billion	39.65 Billion	51.43 Billion	55.95 Billion	47.83 Billion
Other Current Assets	208.33 Million	30.00	211.78 Million	543.26 Million	-10.00	200.00
Total Non-Current Assets	100.03 Billion	100.88 Billion	104.4 Billion	89.42 Billion	89.11 Billion	86.42 Billion
Net PPE	85.31 Billion	85.63 Billion	88.43 Billion	75.77 Billion	75.95 Billion	70.98 Billion
Good Will And Intangible Assets	2.31 Billion	2.67 Billion	1.44 Billion	1.56 Billion	2.21 Billion	2.33 Billion
Good Will	-	-	-	-	-	-
Intangible Assets	2.31 Billion	2.67 Billion	1.44 Billion	1.56 Billion	2.21 Billion	2.33 Billion
Long-Term Investments	2.62 Billion	1.89 Billion	2.74 Billion	2.24 Billion	1.38 Billion	3.94 Billion
Tax Assets	9.78 Billion	10.67 Billion	11.78 Billion	9.83 Billion	9.56 Billion	9.16 Billion
Other Non Current Assets	2.00	19.00	-10.00	10.00	-10.00	-10.00
Other Assets	-	-	-	-	10.00	-
Total Liabilities	136.96 Billion	113.21 Billion	89.2 Billion	73.66 Billion	84.69 Billion	84.5 Billion
Total Current Liabilities	75.05 Billion	49.63 Billion	48.32 Billion	30.14 Billion	39.78 Billion	38.1 Billion
Account Payables	19.4 Billion	20.69 Billion	15.57 Billion	10.08 Billion	13.64 Billion	19.3 Billion
Tax Payables	-	-	-	-	2.5 Billion	-
Short Term Debt	26.01 Billion	11.73 Billion	10.9 Billion	3.33 Billion	8.5 Billion	4.16 Billion
Deferred Revenue	806.76 Million	532.11 Million	19.86 Billion	15.45 Billion	16.41 Billion	13.95 Billion
Other Current Liabilities	28.82 Billion	16.66 Billion	1.97 Billion	1.27 Billion	1.22 Billion	682.64 Million
Total Non Current Liabilities	61.91 Billion	63.58 Billion	40.88 Billion	43.52 Billion	44.9 Billion	46.4 Billion
Long-Term Debt	40.37 Billion	27.58 Billion	2.15 Billion	3.94 Billion	6.12 Billion	8.12 Billion
Deferred Revenue Non Current	-	-	-	-	-	-3.22 Billion
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	21.53 Billion	35.99 Billion	38.72 Billion	39.58 Billion	38.78 Billion	38.28 Billion
Other Liabilities	1.00	-	-	-	-	-
Total Equity	89.63 Billion	89.87 Billion	104.88 Billion	114.43 Billion	115.75 Billion	111.6 Billion
Stock Holders Equity	89.63 Billion	89.87 Billion	104.88 Billion	114.43 Billion	115.75 Billion	111.6 Billion
Common Stock	91.44 Billion	91.44 Billion	91.44 Billion	91.44 Billion	91.44 Billion	91.44 Billion
Retained Earnings	-17.82 Billion	-12.14 Billion	2.86 Billion	12.41 Billion	13.73 Billion	9.58 Billion
Accumulated other comprehensive income	-	-	-	-	-	163.51 Million
Common Stock Equity	89.63 Billion	89.87 Billion	104.88 Billion	114.43 Billion	115.75 Billion	111.6 Billion
Capital Lease Obligation	489.38 Million	695.08 Million	1.76 Billion	823.92 Million	803.47 Million	-
Total Investments	5.62 Billion	506.99 Million	506.99 Million	7.35 Million	7.35 Million	10.35 Million
Total Debt	66.88 Billion	39.32 Billion	13.05 Billion	7.28 Billion	14.62 Billion	12.29 Billion
Net Debt	59.67 Billion	38.63 Billion	12.59 Billion	6.85 Billion	13.97 Billion	10.45 Billion

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	235.65 Billion	233.81 Billion	226.6 Billion	226.6 Billion	219.98 Billion	210.48 Billion
Total Current Assets	134.34 Billion	133.98 Billion	126.56 Billion	126.56 Billion	119.34 Billion	109.51 Billion
Cash And Short Term Investments	15.14 Billion	15.6 Billion	10.2 Billion	10.2 Billion	1.5 Billion	1.39 Billion
Cash and Cash Equivalents	10.14 Billion	10.6 Billion	7.2 Billion	7.2 Billion	1.5 Billion	1.39 Billion
Short Term Investments	5 Billion	5 Billion	3 Billion	3 Billion	-2.08 Billion	-2.69 Billion
Net Receivables	51.82 Billion	52.48 Billion	54.16 Billion	54.16 Billion	55.55 Billion	49.11 Billion
Inventory	66.12 Billion	64.19 Billion	61.98 Billion	61.98 Billion	62.29 Billion	57.64 Billion
Other Current Assets	1.25 Billion	1.7 Billion	208.33 Million	208.33 Million	-10.00	1.35 Billion
Total Non-Current Assets	101.31 Billion	99.82 Billion	100.03 Billion	100.03 Billion	100.63 Billion	100.97 Billion
Net PPE	88.6 Billion	86.3 Billion	85.31 Billion	85.31 Billion	85.02 Billion	84.5 Billion
Good Will And Intangible Assets	1.88 Billion	2.18 Billion	2.31 Billion	2.31 Billion	2.34 Billion	2.48 Billion
Good Will	-	-	-	-	-	-
Intangible Assets	1.88 Billion	2.18 Billion	2.31 Billion	2.31 Billion	2.34 Billion	2.48 Billion
Long-Term Investments	2.04 Billion	2.45 Billion	2.62 Billion	2.62 Billion	2.58 Billion	3.2 Billion
Tax Assets	8.77 Billion	8.87 Billion	9.78 Billion	9.78 Billion	10.67 Billion	10.77 Billion
Other Non Current Assets	-	-6.00	2.00	2.00	-10.00	383.00
Other Assets	-	1.00	-	-	-	-
Total Liabilities	143.31 Billion	140.07 Billion	136.96 Billion	136.96 Billion	132.65 Billion	122.3 Billion
Total Current Liabilities	89.17 Billion	88.04 Billion	75.05 Billion	75.05 Billion	71.39 Billion	59.85 Billion
Account Payables	23.1 Billion	23.56 Billion	19.4 Billion	19.4 Billion	25.92 Billion	25.44 Billion
Tax Payables	212.13 Million	138.85 Million	-	-	33.12 Million	34.13 Million
Short Term Debt	35.99 Billion	36.02 Billion	26.01 Billion	26.01 Billion	17.5 Billion	6.43 Billion
Deferred Revenue	1.07 Billion	1.12 Billion	806.76 Million	806.76 Million	25.36 Billion	25.36 Billion
Other Current Liabilities	29 Billion	27.32 Billion	28.82 Billion	28.82 Billion	2.59 Billion	2.6 Billion
Total Non Current Liabilities	54.13 Billion	52.02 Billion	61.91 Billion	61.91 Billion	61.26 Billion	62.45 Billion
Long-Term Debt	29.79 Billion	30.06 Billion	40.37 Billion	40.37 Billion	38.92 Billion	39.72 Billion
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	24.34 Billion	21.96 Billion	21.53 Billion	21.53 Billion	22.34 Billion	22.72 Billion
Other Liabilities	-	1.00	1.00	1.00	-	-
Total Equity	92.34 Billion	93.74 Billion	89.63 Billion	89.63 Billion	87.33 Billion	88.17 Billion
Stock Holders Equity	92.34 Billion	93.74 Billion	89.63 Billion	89.63 Billion	87.33 Billion	88.17 Billion
Common Stock	91.44 Billion	91.44 Billion	91.44 Billion	91.44 Billion	91.44 Billion	91.44 Billion
Retained Earnings	-15.1 Billion	-13.7 Billion	-17.82 Billion	-17.82 Billion	-14.68 Billion	-13.84 Billion
Accumulated other comprehensive income	-	-	-	-	-	-
Common Stock Equity	92.34 Billion	93.74 Billion	89.63 Billion	89.63 Billion	87.33 Billion	88.17 Billion
Capital Lease Obligation	201.82 Million	297.59 Million	489.38 Million	489.38 Million	1.67 Billion	665.84 Million
Total Investments	7.04 Billion	7.45 Billion	5.62 Billion	5.62 Billion	504.99 Million	504.99 Million
Total Debt	65.98 Billion	66.38 Billion	66.88 Billion	66.88 Billion	56.42 Billion	46.16 Billion
Net Debt	55.84 Billion	55.77 Billion	59.67 Billion	59.67 Billion	54.92 Billion	44.76 Billion

Balance Sheet Charts

Greatek Electronics Inc.

2441

Full Analysis

Annual Balance Sheets
Crixus BH3 Acquisition Company

BHAC

Full Analysis

Annual Balance Sheets
Trevi Therapeutics, Inc.

TRVI

Full Analysis

Annual Balance Sheets
Türk Hava Yollari Anonim Ortakligi

THYAO

Full Analysis

Annual Balance Sheets
I-Sheng Electric Wire & Cable Co., Ltd.

6115

Full Analysis

Annual Balance Sheets
Accelleron Industries AG

ACLIF

Full Analysis

Annual Balance Sheets

Global Stocks Search

Yungjin Pharm. Co., Ltd. (003520.KS)

Annual Balance Sheets

Balance Sheet Charts

Greatek Electronics Inc.

Crixus BH3 Acquisition Company

Trevi Therapeutics, Inc.

Türk Hava Yollari Anonim Ortakligi

I-Sheng Electric Wire & Cable Co., Ltd.

Accelleron Industries AG